Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 27:104:adv40112.
doi: 10.2340/actadv.v104.40112.

The Burden of Multiple Basal Cell Carcinomas: A Population-wide Study

Affiliations

The Burden of Multiple Basal Cell Carcinomas: A Population-wide Study

Johan Kappelin et al. Acta Derm Venereol. .

Abstract

Basal cell carcinoma (BCC) is a common skin cancer type and affected individuals are known to be at risk of developing multiple consecutive tumours. Research into BCC multiplicity has, thus far, been challenging, due to a lack of national registration. This registry-based cohort study aimed to analyse the occurrence of multiple BCCs in Sweden, and risk factors for subsequent primary BCCs. Data regarding all histopathologically verified, primary BCC tumours in Sweden from 2004 to 2017 was extracted from the Swedish BCC Registry. Risk of developing a subsequent BCC in relation to person-related factors was estimated with Cox regression analysis. Cumulative risk of BCC development after 1 or 3 earlier BCCs was estimated. In total, 39.9% of individuals with a registered BCC had at least 2 registered tumours. The risk of developing a subsequent BCC increased significantly in males, older age, and with residence in southern Sweden. The cumulative 5-year risk of developing an additional BCC after first diagnosis was approximately 30% in males and 27% in females and increased after multiple previous BCCs. This study showed the cumulative risk of a subsequent BCC to increase with a history of multiple BCCs, indicating the need for clinical surveillance in these individuals.

PubMed Disclaimer

Conflict of interest statement

JK has received speaker honoraria from Galderma Sweden and Sanofi Sweden. ÅI has received speaker honoraria from Galderma Sweden, Perrigo Sweden, and Biofrontera Sweden. KN has received speaker honoraria from Galderma Sweden, LEO Pharma, Novartis Sweden, and UCB Pharma and has served on one advisory board for MSD. The companies did not influence the study’s design, data collection, analysis, interpretation, or reporting.

Figures

Fig. 1
Fig. 1
Cumulative risk of being diagnosed with a new primary basal cell carcinoma after being diagnosed with one earlier tumour, divided by sex. Presented in a Kaplan–Meier graph.
Fig. 2
Fig. 2
Cumulative risk of being diagnosed with a new primary basal cell carcinoma after being diagnosed with one earlier tumour, divided by age categories. Presented in a Kaplan–Meier graph.

Similar articles

References

    1. Verkouteren JA, Ramdas KH, Wakkee M, Nijsten T. Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol 2017; 177: 359–372. - PubMed
    1. Gordon LG, Rowell D. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review. Eur J Cancer Prev 2015; 24: 141–149. - PubMed
    1. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069–1080. - PubMed
    1. de Vries E, Micallef R, Brewster DH, Gibbs JH, Flohil SC, Saksela O, et al. . Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions. Arch Dermatol 2012; 148: 347–354. - PubMed
    1. Kappelin J, Green AC, Ingvar A, Ahnlide I, Nielsen K. Incidence and trends of basal cell carcinoma in Sweden: a population-based registry study. Br J Dermatol 2022; 186: 963–969. - PubMed

MeSH terms

Supplementary concepts